Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder

Medication Adherence Clinical Trial

Official title: Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder: A Randomized Controlled Trial

Status Completed

Clinical Trial Summary

This study will explore the effect of Adherence Therapy(AT) on medication adherence in patients with schizophrenia spectrum disorder.

Clinical Trial Description

A single-blind, randomized controlled trial with a repeated-measures, two parallel groups design will be conducted for 120 participants with schizophrenia spectrum in regional hospital in northern Taiwan. After baseline data collection finished, the blocked randomization will be employed to assign participants to two groups. The experimental group will participate in a eight session course of Adherence Therapy. The control group received routine care. The data will be collected for baseline(T0) and after 4 session interim analysis(T1；9-12 weeks) and 8 session after intervention(T2；21-28 weeks). A structured Questionnaire will use to collect data on the Medication Adherence Rating Scale, Schedule for the Assessment of Insight, Internalized Stigma of Mental Illness Scale, Self-Appraisal of Illness Questionnaire and Positive and Negative Syndrome Scale. Data analysis will employ Statistical Package for the Social Sciences 20.0 with Generalized estimating equations approach to examine effects of Adherence Therapy and routine care on medication adherence. ;

Related Conditions & MeSH terms

• Medication Adherence
• Motivational Interviewing
• Schizophrenia
• Schizophrenia Spectrum Disorder

• NCT number: NCT04022577
• Study type: Interventional
• Source: National Yang Ming University
• Status: Completed
• Phase: N/A
• Start date: October 1, 2018
• Completion date: September 30, 2019